COGT Chart
See on advanced chart >
About
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases. Cogent's most advanced program, PLX9486, is a highly selective tyrosine kinase inhibitor that is designed to potently inhibit the...
Read More
- HighlightA biotechnology company that focused on developing novel precision immunotherapies to treat cancer
- ExchangeNASDAQ
- Listing Date03/29/2018
- Established DateInvalid Date
- Full-time Employees164
- Address275 Wyman Street 3rd Floor Waltham Massachusetts 02451
- Tel1-617-9455576
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals